Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO2010079161) A B CELL DEPLETING AGENT FOR THE TREATMENT OF ATHEROSCLEROSIS
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/2010/079161 International Application No.: PCT/EP2010/050048
Publication Date: 15.07.2010 International Filing Date: 05.01.2010
IPC:
A61K 39/395 (2006.01) ,C07K 16/28 (2006.01) ,A61P 9/10 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39
Medicinal preparations containing antigens or antibodies
395
Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
16
Immunoglobulins, e.g. monoclonal or polyclonal antibodies
18
against material from animals or humans
28
against receptors, cell surface antigens or cell surface determinants
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
9
Drugs for disorders of the cardiovascular system
10
for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applicants:
INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) [FR/FR]; 101 rue de Tolbiac F-75013 Paris, FR (AllExceptUS)
MALLAT, Ziad [FR/FR]; FR (UsOnly)
AIT-OUFELLA, Hafid [FR/FR]; FR (UsOnly)
TEDGUI, Alain [FR/FR]; FR (UsOnly)
TEDDER, Thomas [US/US]; US (UsOnly)
Inventors:
MALLAT, Ziad; FR
AIT-OUFELLA, Hafid; FR
TEDGUI, Alain; FR
TEDDER, Thomas; US
Agent:
HIRSCH, Denise; Inserm-Transfert 7 rue Watt F-75013 Paris, FR
Priority Data:
09290005.906.01.2009EP
09305013.607.01.2009EP
Title (EN) A B CELL DEPLETING AGENT FOR THE TREATMENT OF ATHEROSCLEROSIS
(FR) AGENT DE DÉPLÉTION DES LYMPHOCYTES B POUR LE TRAITEMENT DE L'ATHÉROSCLÉROSE
Abstract:
(EN) The present invention relates to the prevention or treatment of atherosclerosis, in particular to a B cell depleting agent for the prevention or treatment of atherosclerosis.
(FR) La présente invention concerne la prévention ou le traitement de l'athérosclérose, en particulier un agent de déplétion des lymphocytes B pour la prévention ou le traitement de l'athérosclérose.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
EP2373339JP2012514587US20110275791CN102271710CA2744670KR1020110117652
BRPI1007222ES2630226IN1384/MUMNP/2011